血清白蛋白及其轨迹与溃疡性结肠炎治疗结局相关
该研究汇总5项临床试验共3268例溃疡性结肠炎(UC)患者,评估血清白蛋白水平及其动态轨迹与短期和长期治疗结局的关系。基线和第2周白蛋白是短期结局的独立预测因素,诱导后较高白蛋白预测更好的长期结局;白蛋白轨迹中持续中高、快速上升和反应不良三类,反应不良组长期内镜缓解概率较低。
要点
- 基线白蛋白每升高1 g/L,临床应答的汇总校正比值比(aOR)为1.07(95%CI 1.05-1.09)。
- 诱导后白蛋白较高与更好的长期临床、内镜和组织学缓解相关。
- 白蛋白快速上升至低水平者的结局与持续中高水平者无显著差异。
核心结论
- 较高的白蛋白水平与UC患者更好的治疗结局相关。
- 白蛋白水平低但快速上升的患者可获得与中高水平白蛋白患者相当的结局。
研究设计与样本
- 对5项临床试验共3268例UC患者进行汇总分析。
- 在诱导期和维持期结束时评估短期和长期治疗结局。
- 采用多变量逻辑回归和随机效应模型汇总白蛋白水平的预测效应。
- 采用潜类别增长混合模型拟合白蛋白动态轨迹。
主要发现
- 基线白蛋白每升高1 g/L,临床应答的汇总aOR为1.07(95%CI 1.05-1.09)。
- 第2周白蛋白每升高1 g/L,临床应答的汇总aOR为1.11(95%CI 1.08-1.15)。
- 诱导后白蛋白较高预测更好的长期临床缓解(aOR 1.16;95%CI 1.12-1.21)、内镜缓解(aOR 1.13;95%CI 1.10-1.16)和组织学缓解(aOR 1.11;95%CI 1.03-1.18)。
- 与持续中高类轨迹相比,反应不良类轨迹患者长期内镜缓解概率较低(aOR 0.35;95%CI 0.23-0.50;P < .001)。
- 快速上升类轨迹与持续中高类轨迹之间无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The relationship between serum albumin levels and therapeutic outcomes in ulcerative colitis (UC) has been debated. Additionally, the dynamic changes in albumin levels remain understudied. METHODS: We conducted a pooled analysis of 5 clinical trials involving 3268 patients with UC. Short- and long-term therapeutic outcomes were assessed at the end of the induction and maintenance phases. Multivariable logistic regression and random effects models were used to pool the predictive effects of albumin levels. The dynamic trajectory of albumin was fitted using latent class growth mixed models. RESULTS: Baseline and week-2 albumin were independent predictors of short-term outcomes, with pooled adjusted odds ratios (aORs) of 1.07 (95% confidence interval [CI],1.05-1.09) and 1.11 (95% CI, 1.08-1.15) per 1 g/L increase for clinical response, respectively. Higher post-induction albumin levels predicted better long-term outcomes, including clinical (aOR, 1.16; 95% CI, 1.12-1.21), endoscopic (aOR, 1.13; 95% CI, 1.10-1.16), and histologic remission (aOR, 1.11; 95% CI, 1.03-1.18). Furthermore, there were 3 categories of albumin trajectories: sustained medium-to-high, rapidly ascending, and poor response. Compared with the sustained medium-to-high category, patients in the poor response category had a lower probability of long-term endoscopic remission (aOR, 0.35; 95% CI, 0.23-0.50; P < .001), whereas no significant difference was observed between the rapidly ascending category and the sustained medium-to-high category. CONCLUSION: Higher albumin levels were associated with better therapeutic outcomes in patients with UC. However, patients with low but rapidly ascending albumin levels would achieve outcomes comparable to those with medium-to-high levels of albumin.
引用
- Zheng J, Zhang X, Zhang L, et al. Serum Albumin and Its Trajectory Are Associated With Therapeutic Outcomes in Ulcerative Colitis. Clin Gastroenterol Hepatol. 2024. PMID: 39694206. doi:10.1016/j.cgh.2024.10.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。